Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.

I Bjarnason, B Fehilly, P Smethurst, I S Menzies, A J Levi

Section of Gastroenterology, MRC Clinical Research Centre, Harrow, Middlesex.

Increased small intestinal permeability caused by non-steroidal anti-inflammatory drugs (NSAIDs) is probably a prerequisite for NSAID enteropathy, a source of morbidity in patients with rheumatoid arthritis. This increased small intestinal permeability may be a summation of a local effect during drug absorption, a systemic effect after absorption, and a local effect of the drug excreted in bile, but the relative contribution made by these factors is unknown. We assessed the effect of indomethacin and nabumetone on intestinal permeability. The principal active metabolite of nabumetone, 6-methoxy-2-naphthylacetic acid, is not subject to appreciable enterohepatic recirculation. Twelve volunteers were studied before and after one week's ingestion of indomethacin (150 mg/day) and nabumetone (1 g/day) with a combined absorption/permeability test. Neither drug had a significant effect on the permeation of 3-0-methyl-D-glucose, D-xylose, and L-rhamnose. Indomethacin increased the permeation of radioactive 51chromium ethylenediaminetetra-acetic acid (51Cr EDTA) significantly from baseline (mean (SEM) 0.63 (0.09)% v 1.20 (0.14)%, p less than 0.01) but nabumetone did not (0.70 (0.10)% p greater than 0.1). These results were supported by the 51Cr EDTA/L-rhamnose urine excretion ratios, which reflect changes in intestinal permeability. They suggest that NSAIDs increase intestinal permeability during absorption or after biliary excretion and that the systemic effect is of minor importance.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Watanabe, T, Higuchi, K, Kobata, A, Nishio, H, Tanigawa, T, Shiba, M, Tominaga, K, Fujiwara, Y, Oshitani, N, Asahara, T, Nomoto, K, Takeuchi, K, Arakawa, T (2008). Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 57: 181-187 [Abstract] [Full Text]  
• Smecuol, E, Bai, J C, Sugai, E, Vazquez, H, Niveloni, S, Pedreira, S, Maurino, E, Meddings, J (2001). Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut 49: 650-655 [Abstract] [Full Text]  
• Leite, A Z A, Sipahi, A M, Damiao, A O M C, Coelho, A M M, Garcez, A T, Machado, M C C, Buchpiguel, C A, Lopasso, F P, Lordello, M L, Agostinho, C L O, Laudanna, A A (2001). Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism. Gut 48: 163-167 [Abstract] [Full Text]  
• Sigthorsson, G, Crane, R, Simon, T, Hoover, M, Quan, H, Bolognese, J, Bjarnason, I (2000). COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin. Gut 47: 527-532 [Abstract] [Full Text]  
• Tibble, J A, Sigthorsson, G, Foster, R, Scott, D, Fagerhol, M K, Roseth, A, Bjarnason, I (1999). High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 45: 362-366 [Abstract] [Full Text]  
• Sigthorsson, G, Tibble, J, Hayllar, J, Menzies, I, Macpherson, A, Moots, R, Scott, D, Gumpel, M J, Bjarnason, I (1998). Intestinal permeability and inflammation in patients on NSAIDs. Gut 43: 506-511 [Abstract] [Full Text]  
• Somasundaram, S, Rafi, S, Hayllar, J, Sigthorsson, G, Jacob, M, Price, A B, Macpherson, A, Mahmod, T, Scott, D, Wrigglesworth, J M, Bjarnason, I (1997). Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Gut 41: 344-353 [Abstract] [Full Text]